Advertisement

PROFOUND HYPERTHERMIA ASSOCIATED WITH FENTANYL AND COCAINE USE WITH SUSPECTED SYNEPHRINE ADULTERATION

Published:November 12, 2022DOI:https://doi.org/10.1016/j.jemermed.2022.11.003

      Abstract

      Background: Although hyperthermia is described after cocaine intoxication, the two hyperthermic cases discussed were unusual in severity and duration for cocaine alone. Synephrine was found in biological samples of these patients in high concentrations and was suspected to be an adulterant in illicitly obtained drugs. Case Report: Two patients presented to a tertiary care university hospital within 2 days of each other after recreational drug use with delayed and protracted hyperthermia. Synephrine was later found in high concentrations in biological samples as an unexpected drug adulterant. The first patient's presentation came with delayed recognition of hyperthermia and implementation of aggressive cooling measures; he entered multisystem organ failure with prolonged intensive care unit stay and significant morbidity. The second patient's hyperthermia was recognized promptly, and she received early, aggressive cooling, including deep sedation and ice water submersion. She left against medical advice from the hospital at her baseline 3 days after presentation. Why Should an Emergency Medicine Physician Be Aware of This? Synephrine is a suspected adulterant that may be associated with profound hyperthermia. Early recognition of drug overdose and working knowledge of common adulterants can facilitate early targeted management, such as aggressive cooling measures, which may prevent morbidity and mortality.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Crandall CG
        • Vongpatanasin W
        • Victor RG.
        Mechanism of cocaine-induced hyperthermia in humans.
        Ann Intern Med. 2002; 136: 785-791
        • Marzuk PM
        • Tardiff K
        • Leon AC
        • et al.
        Ambient temperature and mortality from unintentional cocaine overdose.
        JAMA. 1998; 279: 1795-1800
        • Daras M
        • Kakkouras L
        • Tuchman AJ
        • Koppel BS.
        Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome?.
        Acta Neurol Scand. 1995; 92: 161-165
        • Sharma HS
        • Hoopes PJ.
        Hyperthermia induced pathophysiology of the central nervous system.
        Int J Hyperthermia. 2003; 19: 325-354
        • Kosten TR
        • Kleber HD.
        Rapid death during cocaine abuse: a variant of the neuroleptic malignant syndrome?.
        Am J Drug Alcohol Abuse. 1988; 14: 335-346
        • Rossato LG
        • Costa VM
        • Limberger RP
        • Bastos Mde L
        • Remião F
        Synephrine: from trace concentrations to massive consumption in weight-loss.
        Food Chem Toxicol. 2011; 49: 8-16
        • Haller CA
        • Duan M
        • Jacob P
        • Benowitz N.
        Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions.
        Br J Clin Pharmacol. 2008; 65: 833-840
        • Thomas JE
        • Munir JA
        • McIntyre PZ
        • Ferguson MA.
        STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literature.
        Tex Heart Inst J. 2009; 36: 586-590
        • Bouchard NC
        • Howland MA
        • Freller HA
        • Hoffman RS
        • Nelson LS.
        Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine.
        Mayo Clin Proc. 2005; 80: 541-545
        • Jufer RA
        • Wstadik A
        • Walsh SL
        • Levine BS
        • Cone EJ.
        Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers.
        J Anal Toxicol. 2000; 24: 467-477
        • Hengstmann JH
        • Aulepp H.
        Pharmakokinetik und metabolismus von 3H-Synephrin [Pharmacokinetics and metabolism of 3H-synephrine (author's transl)].
        Arzneimittelforschung. 1978; 28: 2326-2331
        • Carpéné C
        • Galitzky J
        • Fontana E
        • Atgié C
        • Lafontan M
        • Berlan M.
        Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
        Naunyn Schmiedebergs Arch Pharmacol. 1999; 359: 310-321
        • Rusyniak DE
        • Sprague JE.
        Toxin-induced hyperthermic syndromes.
        Med Clin North Am. 2005; 89: 1277-1296
        • Baselt Randall C.
        Disposition of Toxic Drugs and Chemicals in Man.
        Biochemical Publications, 2014
        • U.S. Drug Enforcement Administration, Diversion Control Division
        DEA TOX: Quarterly Report-2nd Quarter 2022.
        U.S. Drug Enforcement Administration, 2022